Trial Profile
Phase IIa trial investigating the effects of P1A on gastrointestinal microflora in hospitalised patients treated with combination piperacillin and tazobactam
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2013
Price :
$35
*
At a glance
- Drugs P1A (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Intestinal infections
- Focus Adverse reactions; Pharmacodynamics
- 22 Apr 2013 New trial record